PIIIW

P3 HEALTH PARTNERS INC

• Dow Jones·04/02 14:51

  P3 Health Partners Is Maintained at Hold by TD Cowen

• Dow Jones·04/02 14:51

  P3 Health Partners Price Target Cut to $3.00/Share From $8.00 by TD Cowen

• Benzinga·04/02 14:41

  TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3

• TipRanks·04/02 11:36

  P3 Health Partners price target lowered to $3 from $6 at TD Cowen

• TipRanks·04/01 22:15

  Maintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3

• Dow Jones·03/27 15:12

  P3 Health Partners Price Target Cut to $4.00/Share From $12.50 by Lake Street

• Dow Jones·03/27 15:12

  P3 Health Partners Is Maintained at Buy by Lake Street

• Benzinga·03/27 15:03

  Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4

• TipRanks·03/27 12:56

  Morning Movers: AstraZeneca jumps following tozorakimab trial results

• TipRanks·03/27 12:55

  P3 Health Partners price target lowered to $4 from $12.50 at Lake Street

• TipRanks·03/27 12:50

  Analysts Are Bullish on Top Healthcare Stocks: Insight Molecular Diagnostics (IMDX), Tango Therapeutics (TNGX)

• TipRanks·03/26 23:05

  Closing Bell Movers: Argan jumps 10% on earnings beat

• Reuters·03/26 20:24

  CORRECTED-P3 Health Q4 revenue rises

• Reuters·03/26 20:24

  P3 Health Q4 revenue rises

• Seeking Alpha·03/26 20:21

  P3 Health Partners GAAP EPS of -$23.02 misses by $13.56, revenue of $384.8M beats by $27.15M